Klinische Erfahrungen mit Cefiderocol: Neue Therapieoption bei schweren Infektionen durch multiresistente gramnegative Erreger

BACKGROUND: Infections due to antibiotic-resistant bacteria are threatening modern healthcare, and antibacterial resistance has become one of the greatest threats to public health. In Germany 54,500 patients become infected with antibiotic-resistant bacteria per year, causing about 2400 attributable...

Descripción completa

Detalles Bibliográficos
Autores principales: Witzke, Oliver, Brenner, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Übersichten
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341408/
https://www.ncbi.nlm.nih.gov/pubmed/35913604
http://dx.doi.org/10.1007/s00063-022-00925-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341408/
https://www.ncbi.nlm.nih.gov/pubmed/35913604
http://dx.doi.org/10.1007/s00063-022-00925-5

Ejemplares similares